Previous close | 4.0000 |
Open | 3.9000 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 3.7100 - 3.9000 |
52-week range | 2.8210 - 5.9700 |
Volume | |
Avg. volume | 6,155 |
Market cap | 5.885M |
Beta (5Y monthly) | 2.58 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Xenetic Biosciences ( NASDAQ:XBIO ) First Quarter 2024 Results Key Financial Results Revenue: US$510.8k (down 16% from...
Xenetic Biosciences (XBIO) delivered earnings and revenue surprises of 1.27% and 21.39%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Xenetic Biosciences ( NASDAQ:XBIO ) Full Year 2023 Results Key Financial Results Revenue: US$2.54m (up 49% from FY...